ETIDRONATE DISODIUM ORAL CAPSULES 400 MG PLACEBO, ETIDRONATE DISODIUM ORAL CAPSULES 400 MG
22U-0320
Phase 2 small_molecule active
Quick answer
ETIDRONATE DISODIUM ORAL CAPSULES 400 MG PLACEBO, ETIDRONATE DISODIUM ORAL CAPSULES 400 MG for Fahr's disease, Fahr's syndrome is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Fahr's disease, Fahr's syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active